Blog

Education · 7 min read

How to Get Tirzepatide Prescribed Online in Georgia

How Georgia residents get tirzepatide prescribed online — legitimate channels only: brand-name Zepbound®/Mounjaro® and compounded tirzepatide under §503A, plus who can prescribe, shipping, and counterfeit red flags.

Reviewed byPallas Clinical TeamSep 11, 20267 min read

Georgia residents have exactly two legitimate ways to get tirzepatide online: a prescription for the FDA-approved brand-name product (Zepbound® or Mounjaro®, both made by Eli Lilly) or a compounded preparation from a US-licensed compounding pharmacy under FDCA §503A — and both require a Georgia-licensed clinician to review your health history first. Everything else — a site that ships tirzepatide with no prescription, or labels it "research use only" — isn't a cheaper third option. It's outside the law. See our Georgia state page for current availability, or read on for exactly how the legitimate process works for Georgia residents.

The short answer

Legitimate tirzepatide online for Georgia residents comes from one of two places: a licensed pharmacy filling a prescription for FDA-approved Zepbound® or Mounjaro®, or a US-licensed compounding pharmacy preparing tirzepatide per-patient under §503A when a Georgia-licensed clinician documents a specific clinical rationale. Both paths start with the same real health questionnaire, reviewed by a clinician licensed in Georgia — no legitimate provider skips that step, regardless of price.

How do I get tirzepatide prescribed online in Georgia?

The process is the same two-step structure used for any GLP-1 in Georgia, applied to tirzepatide specifically:

  1. You complete an online intake. Medical history, current medications, prior GLP-1 or tirzepatide use, and your goals — typically 5–10 minutes.
  2. A Georgia-licensed clinician reviews it, usually asynchronously by secure message. Georgia doesn't require a video visit by state rule for non-controlled medications like tirzepatide, so most patients never schedule one — though a clinician may ask for a brief video visit or additional labs if your history calls for it.
  3. The clinician decides whether tirzepatide is appropriate, and if so, which form — brand-name or compounded — fits your situation. This is a clinical decision, not a guarantee tied to submitting a form.
  4. A licensed pharmacy fills the prescription and ships it to your Georgia address, typically within 2–3 business days of the pharmacy filling the order.

That process doesn't change based on where in Georgia you live — whether you're in Atlanta, Augusta, Columbus, Savannah, Athens, or out toward rural South Georgia and the coastal Golden Isles, the intake, the clinician review, and the shipping timeline are the same. For the fuller national walkthrough of each step, including what disqualifies someone, see how to get tirzepatide online; this piece focuses on what's specific to Georgia.

Who can prescribe tirzepatide to a Georgia resident?

Georgia requires any clinician prescribing to a Georgia resident to hold an active Georgia medical license — a license from another state isn't enough, even for an otherwise identical telehealth visit. That authority isn't limited to physicians: nurse practitioners can also prescribe tirzepatide under a nurse protocol agreement, a written delegation arrangement with a Georgia-licensed physician filed with the Georgia Composite Medical Board under O.C.G.A. §43-34-25. Tirzepatide is not a controlled substance, so Georgia permits the entire process — intake, prescription, and follow-up — through telehealth, as long as the treating clinician holds active Georgia licensure or a filed nurse protocol agreement.

Check your eligibility in Georgia

Complete a short health questionnaire and a Georgia-licensed clinician will review whether tirzepatide is appropriate for you — most patients never need to schedule a video call.

Start your intake →

Zepbound® vs. Mounjaro®: which one gets prescribed?

Zepbound® and Mounjaro® are the same molecule, tirzepatide, made by the same manufacturer, Eli Lilly — but they carry different FDA-approved indications. Zepbound® is approved for chronic weight management; Mounjaro® is approved for type 2 diabetes. Which one a Georgia-licensed clinician prescribes depends on your diagnosis, not on which is easier to find. Brand-name tirzepatide dispensed through Pallas is cash-pay only and is not billed to insurance.

Is compounded tirzepatide legitimate in Georgia?

It can be — legitimacy depends on the pharmacy and the clinician behind it, not on the fact that it's compounded. A US-licensed compounding pharmacy operating under §503A is a real, regulated source, and Georgia residents are eligible for compounded tirzepatide when a Georgia-licensed clinician documents a patient-specific clinical rationale. What makes a compounded tirzepatide prescription legitimate in Georgia, specifically:

  • A named, licensed pharmacy. A legitimate provider can tell you exactly which US-licensed pharmacy prepares your medication.
  • A Georgia-licensed clinician's documented rationale. Both the tirzepatide shortage (resolved December 19, 2024) and the semaglutide shortage (resolved February 21, 2025) have ended, so shortage status no longer justifies a compounded prescription anywhere, including Georgia. Under §503A(b)(1)(C), your clinician compounds only when they document a patient-specific clinical reason an FDA-approved product isn't appropriate for you — not for price or preference alone.
  • A real clinician review, the same standard as any brand-name prescription.

Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.

Does Georgia Medicaid cover tirzepatide?

Only in limited circumstances. Georgia Medicaid covers tirzepatide (Mounjaro®) for type 2 diabetes with prior authorization, but coverage for tirzepatide prescribed for weight loss (Zepbound®) is limited, with step therapy required before approval. Compounded tirzepatide is not covered at all. Pallas is a cash-pay telehealth service — no insurance is billed for either tier — so this doesn't change how the intake or pricing works with us, but it's worth knowing if you were assuming Medicaid coverage applied. For current pricing, see what tirzepatide costs and the Georgia cost page.

What makes an online tirzepatide seller illegitimate?

The pattern is consistent whether the site is selling "generic Zepbound," "research tirzepatide," or something with a made-up brand name entirely:

  • No prescription required. Tirzepatide is a prescription medication everywhere in the US, including Georgia. Any seller willing to ship it without a clinician's review is operating illegally.
  • "Research use only" or "not for human use" labeling. This signals the product isn't intended, tested, or regulated as a medicine — it isn't a legal workaround for selling it as one.
  • The seller won't name its pharmacy. A legitimate telehealth provider can tell you exactly which licensed pharmacy — retail or a named compounding pharmacy — is filling your order.
  • No verifiable certification. LegitScript maintains a public database of certified healthcare merchants. Check any provider — including Pallas — before paying, and confirm the certification is current.
  • Prices that don't add up. A price far below what named, licensed providers charge, from a source that won't say where the drug comes from, is a counterfeit or unregulated-sourcing risk, not a bargain.

Two free lookups cover most of the verification: LegitScript's certification database for the provider, and the FDA's BeSafeRx locator to confirm the pharmacy itself is state-licensed. You can also check any Georgia-licensed clinician directly through the Georgia Composite Medical Board's license lookup.

The bottom line

Georgia residents can get tirzepatide prescribed online through a real clinical process: an intake questionnaire, review by a Georgia-licensed clinician (physician or NP), a prescribing decision based on your history, and fulfillment through a licensed pharmacy — for either FDA-approved Zepbound®/Mounjaro® or compounded tirzepatide prepared under §503A. No video visit is required by state rule, and a seller offering tirzepatide without a prescription or a named pharmacy isn't a cheaper option — it's outside the system that makes any of this safe to trust. Learn more about GLP-1 treatment at Pallas or start with the Georgia state page for current specifics.

Frequently asked questions

Start Pallas's online intake and share your health history, goals, and current medications — it takes about five minutes. A Georgia-licensed clinician (physician or NP under a nurse protocol agreement) reviews it asynchronously (no video visit required by state rule) and, if tirzepatide is clinically appropriate, prescribes it based on your documented history. Pallas offers both compounded tirzepatide, prepared per-patient by US-licensed pharmacies under FDCA §503A when your clinician documents a patient-specific clinical rationale, and FDA-approved Zepbound® and Mounjaro® (Eli Lilly), through the same intake. A US-licensed pharmacy then ships your prescription to your Georgia address.

No — Georgia is one of the 43 async-first states. A Georgia-licensed clinician can review your intake by secure message and, if appropriate, prescribe tirzepatide without ever scheduling a video call, as long as the standard of care is met. A clinician may ask for a brief video visit or additional labs if your history calls for it, but most patients complete everything asynchronously.

Both are tirzepatide made by Eli Lilly, so they contain the same active ingredient. They differ in FDA-approved indication: Zepbound® is approved for chronic weight management, and Mounjaro® is approved for type 2 diabetes. Your Georgia-licensed clinician prescribes based on your diagnosis.

Yes. Compounded tirzepatide prescribed by a Georgia-licensed clinician and dispensed by a licensed compounding pharmacy is legal when prepared for an individual patient based on a documented clinical rationale under FDCA §503A. It is not FDA-approved, is not a generic version of Zepbound® or Mounjaro®, and has not been evaluated by the FDA for safety, efficacy, or quality — a legitimate provider will always say so. Pallas only works with US-licensed 503A and 503B compounding pharmacies.

Not for weight loss. Georgia Medicaid covers tirzepatide (Mounjaro®) for type 2 diabetes with prior authorization, but coverage for tirzepatide prescribed for weight loss (Zepbound®) is limited and requires step therapy. Compounded tirzepatide is not covered at all. Pallas is a cash-pay service, so this doesn't change your intake or pricing with us either way.

Check for a real health questionnaire and review by a Georgia-licensed clinician (not just a payment form), a named US-licensed pharmacy preparing or dispensing your medication, no willingness to ship without a prescription, and verifiable LegitScript certification. You can also confirm a clinician's Georgia license through the Georgia Composite Medical Board's license lookup before paying any provider, including Pallas.

See if tirzepatide is right for you

Pallas's intake is asynchronous for Georgia residents — complete it by message, and a Georgia-licensed clinician will let you know if tirzepatide is appropriate for you. No insurance needed, cancel anytime.

Start your intake →

Trademarks & disclosures

Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by Eli Lilly. Brand-name tirzepatide dispensed through Pallas is cash-pay only and is not billed to insurance. Prescriptions — brand-name or compounded — are written only when a Georgia-licensed clinician determines treatment is appropriate.